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Summary The effect of ionising radiation on the regulation of gene and protein expression is complex. This
study focuses on the translational regulational of the epsilon isoform ofprotein kinase C by ionising radiation.
We found that protein kinase C is rapidly increased in the human lung adenocarcinoma cell line A549
following irradiation. Western blots showed increased accumulation of this protein at doses as low as 75 cGy
after 15 min post irradiation. Maximal induction (11-fold over unirradiated cells) of PKC occurred at
150 cGy within 1 h after treatment by X-rays in A549 cells. The increased levels of PKC 8 protein after
X-rays does not require de novo protein or RNA synthesis, suggesting that this increase is post-translationally
controlled. In contrast to A549 cells PKC levels in the large cell lung carcinoma cell line NCI H661 were
not induced by radiation. In the small cell lung carcinoma cell line NCI N417, PKC 8 was also not induced
but a higher molecular weight PKC protein, suggestive of phosphorylation, appeared at 2 h after irradia-
tion. The variation in induction or phosphorylation of PKC by ionising radiation in the cell lines tested in
this study suggested that no clear correlation existed between intrinsic radiation sensitivity and PKC
induction. To determine whether PKC does play a role in cell survival to irradiation, we used the protein
kinase inhibitor staurosporin to decrease PKC activity and found that staurosporin sensitised cells to killing by
ionising radiation. Pulsed field gel electrophoresis, however, indicated that DNA double-strand break repair
was not decreased, suggesting that PKC e is modifying the fidelity of rejoining and not the overall magnitude
of repair. The regulation of PKC by ionising radiation will be discussed with respect to the biological
consequences of gene induction by DNA damage agents.
In prokaryotes ionising radiation induces a series of genes
which are involved in DNA repair processes (Walker, 1985).
For eukaryotic cells the data are still ambiguous as to wheth-
er the genes or proteins induced by DNA damaging agents
are involved in DNA repair. Evidence for the presence of
inducible DNA repair genes in mammalian cells comes from
the work of Wolff et al. (Wolff et al., 1988). They showed
that if lymphocytes are pretreated with low doses of a DNA
damaging agent such as X-rays or bleomycin, they become
more resistant to cytogenetic damage when challenged with a
higher dose of the same agent. Further evidence that induci-
ble DNA repair processes exist in mammalian cells is found
in the work of Boothman et al., which demonstrates by
two-dimensional gel electrophoresis that a specific set of
proteins are induced when cells are irradiated and held under
conditions which prevent them from cycling before they can
repair their potentially lethal DNA damage (PLDR-Poteh-
tially Lethal Damage Repair) (Boothman et al., 1989). Inter-
estingly, one protein designated XIP 269 (X-ray inducible
protein with an apparent molecular weight of 260 kilodal-
tons) showed a good correlation between its induction and
the extent of PLDR in a variety of different cell lines. How-
ever, this protein is still unidentified.
The molecular trigger for the induction of genes and pro-
teins by ionising radiation has not been elucidated but most
probably involves the activation of pre-existing proteins since
the kinetics of their activation is rapid. Sherman et al. have
recently reported the induction of the proto-oncogenes c-jun,
jun B anc c-jun by ionising radiation, suggesting that the
damage produced by ionising radiation activates transcrip-
tional regulators (Sherman et al., 1990). UV light and other
DNA damaging agents also induce c-fos and c-jun, impli-
cating DNA damage as a cellular sensor for gene activation
(Hollander & Fornace, 1989). Regulation of transcriptional
factors, in general, is not dependent on de novo protein or
RNA synthesis, indicating that post-translational
modification of pre-existing proteins, such as phosphoryla-
tion, is responsible for their DNA binding activation. One
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example of a transcriptional factor activated by ionising
radiation is the AP-1 protein. AP-1 is composed of homo or
heterodimers of c-fos and c-jun which bind to DNA to
stimulate transcription of genes responsive to phorbol esters
and growth factors (Angel et al., 1987). The similarity of the
response of increased transcription of c-jun, jun B and AP-1
after ionising radiation and after growth factors suggests that
they might occur through a common activation mechanism
such as PKC.
Recently there has been strong evidence for the involve-
ment of signal transduction pathways, especially those invol-
ving PKC, as the link between radiation damage and the
activation oftranscription factors. At present, genes activated
by ionising radiation can be broadly classified as PKC depen-
dent or PKC independent. PKC dependent genes respond
relatively rapidly within minutes post irradiation (Hallahan et
al., 1991b) and PKC independent genes require at least 5 h
for maximal activation (Fornace et al., 1988; Papathanasiou
et al., 1991). Hallahan et al. have reported that both tumour
necrosis factor (TNF) gene expression (Hallahan et al.,
1991b) as well as EGR-1 and JUN gene expression (Hallahan
et al., 1991a) are mediated by protein kinase C following
radiation. These data further implicate PKC as a regulator of
gene expression by ionising radiation. However, it still re-
mains to be determined whether PKC is the master regulator
of early gene responses.
Thus far, eight distinct isoforms of PKC have been
identified, exhibiting tissue specific expression and differences
in their mode of activation and substrate specificity
(Coussens et al.). At the DNA level these genes share some
sequence homologies and are genetically distinct as they are
located on different chromosomes (Nishizuka, 1988). This
study focuses on the epsilon (e) isoform of protein kinase C
which is found in brain (Heidenreich et al., 1990), thymocytes
(Strulovici et al., 1990), and small cell carcinomas of the lung
(Baxter et al., 1992). To determine what effect ionising radia-
tion has on the expression of the PKC a isoform, we
analysed the kinetics of PKC induction in a variety of human
lung tumour cell lines following x-irradiation. In addition, we
found that inhibition of PKC by staurosporin sensitised cells
to X-rays without affecting their ability to repair DNA dou-
ble strand breaks.
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Materials and methods
Cell lines and culture conditions
Human lung adenocarcinoma A549 cells were obtained from
the American Type Culture Collection (ATCC) and routinely
cultured in alpha MEM containing 10% foetal calf serum.
The small cell lung carcinoma cell lines used in this study
were: classic small cell carcinoma cell lines: NCI H69, NCI
H209, NCI H345, NCI H146 and variant cell lines: NCI
H82, NCI-N417, NCI H526, NCI 841, NCI-H524. The large
cell line used was a NCI H661. These cell lines were estab-
lished by Adi Gazdar and generously provided by Dr John
Minna (NCI, Bethedsa, Md) and cultured in RPMI 1640
medium with 10% heat inactivated serum. These cell lines
have been previously described by Carmichael et al. with
respect to their radiation sensitivity (Carmichael et al., 1989)
and biochemical and morphological properties (Carney et al.,
1985; Gazdar et al., 1985). To reduce the effects of serum on
PKC induction, cells were refed 16 h before the experiment
with alpha MEM or RPMI containing 0.1% BSA before
induction experiments. To down regulate PKC, l0-7 M TPA
was added for 16 h before irradiation. Cells were irradiated
at room temperature using either a Torex 150D X-ray
cabinet at a dose rate of 0.45 Gy min-' or a '37Cs source at a
dose rate of 310 Gy min-'. To determine whether induction
required de novo protein or RNA synthesis, cells were prein-
cubated for 1 h with either 1 Ag ml-' or cyclohexamide or
Ofig ml-' of actinomycin D before irradiation.
Protein isolation and immunoblotting
Cytosolic and particulate extracts of cells were prepared as
previously described by Heidenreich et al. by lysing 5 x 106
cells on ice in buffer containing 10% SDS, 5% P-mercap-
toethanol, 10% glycerol in 25 mM Tris-HCI, pH 6.8, and
then sonicating the cells (Sonifier cell disruptor model W185
Heat systems-Ultrasonics, Inc.) at setting 7 for four three-
second intervals on ice (Heidenreich et al., 1990).
Two hundred ltg of the protein extract was boiled for
5 min and subjected to one dimensional SDS/page as des-
cribed by Laemmli (1970). After electrophoresis, immuno-
blotting of the separated proteins onto nitrocellulose paper
was performed overnight at 250 mA by the method of Tow-
bin et al. using a Biorad blotting apparatus (Towbin et al.,
1979). For immunological detection of the PKC £ protein,
polyclonal antibodies previously described by Strulovici et al.
(1991) were used at a dilution of 1:300 (Heidenreich et al.,
1990). These antibodies specifically recognise the PKC e
isoform. PKC e was confirmed as the major reacting antigen
by including a lane on the gel of rat brain extract which is
highly enriched for this isoform. Nonspecific sites were first
blocked by incubating the nitrocellulose paper with 5% in-
stant nonfat milk (Carnation) and 0.5% Tween 20 for 1 h at
37°C. After blocking the non-specific sites, the nitrocellulose
membrane was incubated for 4 h with a 1:200 dilution of
antisera in 5% Carnation instant non-fat milk, 0.5% Tween
20 buffer, washed twice in the same solution without anti-
body, and then incubated with 0.1 tLCi ml-' of 1251I-protein A
(Amersham) for 1 h. After three more washes of 10 min each,
the nitrocellulose paper was dried at room temperature, and
exposed to Kodak XAR-1 film with intensifying screens at
- 70° for 3 to 7 days. Quantitation of PKC induction was
determined using a LKB 2272-020 ultrascan excel enhanced
scanning laser densitometer with gel scan XL-software.
Radiation response
Survival curves to assay for cellular radiation sensitivity were
performed on cells that were depleted of serum for 16 h as
described above. Cells were untreated or pre-treated 1.5 h
before irradiation with varying concentrations of stauro-
sporin (50-500 nM). Some cells also received an additional
1.5 h of staurosporin treatment post irradiation. All cells
were then washed twice and plated in six-well plates (Costar).
Clonogenic survival was determined after incubation at 37°C
for 10 days by fixing colonies with 10% formalin and stain-
ing with 1% crystal violet solution for counting. Colonies of
50 cells or more were counted. Survival curve was generated
from three experiments with three replicates per point.
Pulsed-fieldgel electrophoresis
The procedure of Giaccia et al. (1990) for asymmetrical-field
inverted gel electrophoresis was used to determine the effect
of staurosporin on the rejoining rate of DNA double-strand
breaks in A549 cells by determining their rejoining capacity
after 2500 cGy. Briefly, 5 x 105 A549 cells were initially
plated onto 100 mm2 plates with 12 ml alpha MEM contain-
ing 10% FCS and 0.24 iCiml-1 methyl 14C-thymidine (40
mCimmole-1, Amersham). After 2-3 days, the cells were
refed with alpha MEM containing 0.1% BSA and 0.24plCi
methyl '4C-thymidine per ml for 16-20 h. The cells were then
washed with alpha MEM containing 0.1% BSA and incuba-
ted for 1.5 h in the same media to remove unincorporated
radioactive thymidine. The cells were then incubated for 1.5 h
with 500 nM staurosporin in alpha MEM containing 0.1%
BSA, irradiated with 2500 cGy and then inbeded in 1%
agarose (Insert agarose-FMC, Rockland, ME) following
incubation at 37C for 0, 0.5, 1.0, and 3.0 h after irradiation.
For each experiment unirradiated and untreated controls
were also included. The agarose solution containing the cells
was cast into 3 mm diameter glass tubes, cut into 5 mm
cylinders, and then lysed for 24h in 10 volumes of lysis
buffer (0.5 M EDTA pH 7.9, 1% Sarkosyl, 1 mg proteinase
K ml-1) (Boehringer Mannheim, Indianapolis, IN) at 50°C.
After this lysis period, the plugs were then dialysed twice
against 25-50 vol of TE (10 mM Tris pH 7.4, 1 mM EDTA)
and then incubated for 1 h in TE containing 0.1 mg of
ribonuclease A per ml (Boehringer-Mannheim). These RNA
free plugs were then loaded into 2 mm wells of an 0.8%
agarose gel and asymmetrically electrophoresed (Denko et
al., 1989) for 16-24 h. The conditions for AFIGE were 900 s
at + 1.25 V cm-' and 75 s at - 5.0 V cm-'. Under these
conditions, marker chromosomes from Schizosaccharomyces
pombe and Saccharomyces cerevisea of 5.7 Mb or less will
enter the gel, while larger DNA fragments will not be eluted
into the lane from the well. For quantitation, the wells were
separated from the lanes by a scalpel and each individually
placed into a scintillation vial. Before melting on the agarose,
50ml of IONHCl was added to prevent the agarose from
repolymerising. Scintillation fluid was then added to the sam-
ples, and they were counted on a Beckman LS 60001C scintil-
lation counter. The % of DNA double-strand breaks
rejoined was determined by the formula:
(% DNA released after treatment at time t) -
1- (% DNA released after no treatment at time t) x 100 (% DNA released after treatment at Oh) -
(% DNA released after no treatment at 0 h)
For untreated controls, the amount of DNA released from
the wells ranged from 1-3%.
Results
Induction ofPKC epsilon
Previous experiments of Woloschak et al. (Woloschak et al.,
1990) demonstrated that ionising radiation increased PKC P
mRNA levels in syrian hamster embryo fibroblasts. This 4-6
fold increase in PKC resulted after 75 cGy of X-rays, a
relatively low dose in relation to individual doses used in
cancer treatment. It seemed a strong possibility to us that a
second level of regulation by ionising radiation could occur
at the translational level. Therefore, we analysed the induc-
tion of PKC epsilon protein in lung carcinoma cell lines
using a specific antibody against this isoform.
The time course of PKC induction following irradiation
with a single dose of 75 cGY was determined by Western
blotting and is shown in Figure 1. The effect of ionising846 C.Y. KIM et al.
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Figure 1 Western blot of time course of PKC epsilon induction
by 75 cGy of ionising radiation in three lung carcinomas (A549,
NCI H661, NCI N417). The phorbol ester TPA was used as a
control to downregulate PKC epsilon levels. The marker was
derived from mouse brain extract which is highly enriched for
PKC epsilon. NCI N417 insert b is a lighter exposure of insert a
to illustrate covalent modification seen at 2 and 3 h.
radiation on the PKC a isoform in the adenocarcinoma cell
line A549 was quite rapid, with maximum induction by
15 min after irradiation. After 2 h, the levels of PKC a
returned to those of untreated controls. In contrast to A549
cells, the levels of PKC a were unaffected by ionising radia-
tion in NCI H661 cells derived from a large cell carcinoma.
A third lung carcinoma cell line NCI N417 which originated
from a small cell lung carcinoma also showed no change in
PKC induction by ionising radiation. However, we noticed
the appearance of a higher molecular weight protein that was
recognized by our antibody at 2 h post irradiation (NCI
N417 b). The appearance of this band suggests a post-
translational modification of the 90 kDa PKC a protein,
most probably phosphorylation.
Since the induction of PKC a in A549 cells occurred at
relatively low doses of ionising radiation, we investigated
whether its induction was dose dependent. As seen in Figure
2, PKC epsilon induction increased linearly for 1 h following
a dose of 150cGY. Interestingly, the kinetics of induction
after 225 cGy were similar to those at 75 cGy. This suggests
that a maximum protein induction exists in A549 cells at
relatively low doses. Most importantly, PKC c is induced
strongly and rapidly in this cell line.
The effect oftranscription or translation inhibitors on PKC
induction
Due to the rapid induction of PKC e by ionising radiation
in A549 cells, we investigated whether this induction required
de novo RNA or protein synthesis. Pretreatment of cells with
10jg ml- of actinomycin D (total RNA synthesis reduced
to 7% of untreated as measured by 3H-uridine incorporation)
+ A.D.
NT 0 0.25 0.5 1 2 TPA
or with 1 sgml1- cycloheximide (total protein synthesis re-
duced to 18% of untreated as measured by 3H-leucine incor-
poration) for 1 h, followed by 75 cGy resulted in no change
in PKC induction, but did result in the appearance of a
second higher molecular weight band (Figure 3). Although
we have not determined the relationship between these two
bands, it is most probable that the higher molecular weight
band represents a post-translational modification (phosphor-
ylation) of the protein.
Biological effects ofinhibition ofprotein kinases on survival
and DNA double-strand break rejoining
To determine the relationship between PKC induction and
survival, we inhibited PKC activity by preincubating the cells
with the microbial alkaloid staurosporine and assessed the
effect it had on cellular sensitivity to killing by ionising
radiation. Preincubation of cells for 1.5 h with varying con-
centrations of staurosporin (50-500 nM) followed by irradia-
tion and a subsequent 1.5 h incubation resulted in a dose
dependent decrease in cellular survival (Figure 4). The staur-
osporin treatment itself resulted in 14% decrease in survival
at 50 and 100nM concentrations, and a 28% decrease in
survival at a 500 nM concentration. Analysis of the survival
curve showed that staurosporin had little effect on the initial
part of the survival curve (0-400 cGy), but decreased the
slope at higher doses (400-800 cGy) of the curve. This data
suggests that inhibition of PKC interferes with the cellular
response to rather larger doses of ionising radiation, but not
to small ones. This result is puzzling in light of the fact that
the induction of PKC a occurred at doses of 75 cGy. How-
ever, it must be noted that staurosporin is a general protein
kinase inhibitor (Badwey et al., 1991), and the possibility
remains that the sensitisation that we saw may not neces-
sarily be due to PKC inhibition alone.
Since staurosporin was able to sensitise cells to killing by
ionising radiation, we used AFIGE to determine whether this
sensitisation was the result of inhibition of DNA double
strand break rejoining. Figure 5 shows the kinetics of DNA
0
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Figure 2 Time course of PKC epsilon induction in A549 cells as
a function of varying doses of ionising radiation (75, 150,
225 cGy). The time course of induction is similar for the three
doses, with peak induction at 75 cGy occurring in 15 min, at 150
cGy in 1 h, and at 225 cGy in 30 min.
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Figure 3 Western blot of the effect of inhibitors of RNA synthesis (1OiLg ml- Actinomycin D) and protein synthesis (1 sgml-'
Cyclohexamide) on the time (in hours) of induction of PKC epsilon in A549 after treatment with 75 cGy. NT = untreated. PKC
levels were unaffected, suggesting that induction does not require de novo RNA or protein synthesis.PROTEIN KINASE C a PROTEIN IN LUNG CANCER CELLS 847
Table I Relationship between radiosensitivity
induction
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Figure 4 The effect of a protein kinase inhibitor, staurosporin,
on survival of A549 cells after treatment with 200, 400, and
800 cGy. A549 cells were pretreated for 1.5 h before irradiation.
The 0, 50, 100 and 500 nm treatments were also post treated for
1.5 h after irradiation. The 500 nM-Post received no staurosporin
post treatment. At 200 and 400 cGy there were no significant
differences in survival fraction. At 800 cGy, however, surviving
fraction decreased with increasing staurosporin concentration,
suggesting that inhibition of protein kinases sensitised the cells to
radiation.
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Figure 5 Rejoining kinetics of DNA double-strand breaks in
A549 cells after 2500 cGy treated or untreated with 250 gM
staurosporin.
double-strand break rejoining in A549 cells. Both treated and
untreated cells have similar rejoining kinetics with a half time
of 30 min. Therefore, the sensitisation of A549 cells to killing
by staurosporin seems to be independent of DNA double-
strand break rejoining, per se. It is possible that the fidelity
of rejoining is altered in the staurosporin treated cells. To
determine if the fidelity of rejoining is grossly altered,
chromosome aberration studies will be required.
Finally, to determine whether a correlation exists between
radiosensitivity and PKC induction, we compared the
surviving fraction after 200 cGy, to both steady state PKC a
levels and induction of PKC a 1 h after radiation in 11 lung
cell lines. The cell lines in this study failed to demonstrate a
relationship between surviving fraction and either constitutive
or inducible PKC a levels (Table I). Other than A549, one
other cell line, H82, a variant cell line, was found to exhibit
significant induction. Of note this cell line has undetectable
levels of constitutive PKC a protein.
Small cell' SF 2G)i PKC Sc Inductiond
Classic
NCI H69 0.23 + + -
NCI H209 0.37 +
NCI H345 0.21 + + N.D.e
NCI H146 0.066 + + +
Variant
NCI N417 0.56 + + +
NCI H82 0.73 - 4-fold
NCI H526 0.72 +
NCI 841 0.85 + + N.D.
NCI H524 not done +
Large cell
NCI H661 0.93 +
Adenocarcinoma
A549 0.82 + 5-fold
aClassification of tumour histology has been previously described
in Carney et al., 1985, Cancer Res., 45, 2913-2923 and Gazadar et
al., 1985, Cancer Res,. 45, 2924-2929. bRadiation sensitivity of
human lung cancer cell lines derived from Carmichael et al., 1989,
Eur. J. Cancer Clin Oncol., 25, 527-534. Surviving fraction following
a 200 cGy dose. cThe relative level of PKC a protein cross reacting
with antibody. The steady state levels of PKC epsilon were com-
pared intraexperimentally with one another and grouped according
to their relative levels (-, +, + +, + + +). dInduction of PKC a
protein at I h post radiation with 75 cGY. --- indicates no induc-
tion. 'N.D. = Not Determined.
Discussion
In this paper we have described the transient accumulation of
the PKC a protein by ionising radiation in the A549 cell
line. PKC a induction occurred at low doses of ionising
radiation within 15 min post irradiation suggesting that PKC
induction might be useful as a biomarker/biodosimeter for
ionizing radiation treatment in some tumour cell types,
especially since the dose range for its induction is in the
range of doses given in fractionated radiotherapy (100-200
cGy). Specifically, its usefulness as a biomarker could be
applied to sections of tumour biopsies with polyclonal anti-
bodies that recognise common epitopes for all PKC isotypes.
Alternately, the polymerase chain reaction could be used to
detect increased levels of PKC mRNA. Although PKC
induction would be useful as a biomarker, the relationship
between its induction and intrinsic cellular radiosensitivity is
unclear.
Hirai et al. found that some lung cancer cell lines derived
from squamous cell carcinomas, small cell carcinomas, or
adenocarcinomas exhibit high levels of PKC activity com-
pared to malignancies found at other sites (Hirai et al., 1989).
Lung carcinomas in general are responsive to radiation
therapy, with the small cell lung cancer (SCLC) being more
sensitive to radiation therapy than the other histological
subtypes of lung cancer. Some cell lines derived from SCLC,
however, exhibit a variant phenotype which may be more
radioresistant than the classic phenotype (Carmichael et al.,
1989). Our data suggest that no clear correlation exists
between PKC a and surviving fraction. However, more work
is needed to validate these results.
Interestingly, we found that the protein kinase inhibitor
staurosporin is able to sensitise cells to killing by ionising
radiation, seemingly independent of an effect on DNA dou-
ble-strand break rejoining. To detect a difference in DNA
double-strand break rejoining after treatment by stauro-
sporin, we used the highly sensitive method ofpulsed field gel
electrophoresis. Since we saw no difference in DNA rejoining
ability between staurosporin treated and untreated cells, we
may assume that staurosporin sensitises cells to killing by
ionising radiation by increasing DNA misrejoining, leading
to higher levels of chromosome aberrations. This hypothesis
will be tested by analysing chromosome aberrations induced
by ionising radiation in treated vs untreated cells. However, it
is possible that staurosporin is not affecting DNA/chromo-
and PKC C
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some rejoining directly, but is altering cell cycle progression
or G2-phase delay. These possibilities are more likely as
staurosporin is a general protein kinase inhibitor (Badwey et
al., 1991) and many cell-cycle regulated events are mediated
by protein phosphorylation and dephosphorylation (Gould &
Nurse, 1989). In addition, PKC induction may not neces-
sarily be a positive event, since it has an important role in
tumour promotion.
The various PKC isotypes have different activation re-
quirements. Several groups have reported that phosphoryla-
tion of protein kinase C results in a lower Ka for Ca2+ and a
higher affinity for binding phorbol esters (Huang et al., 1986;
Fry et al., 1985). Recently, Molina and Ashendel have dem-
onstrated PKC phosphorylation in cells by treatment with
TPA or DiC8 (sn - 1,2-dioctanoylglycerol), direct activators
of PKC (Molina & Ashendel, 1991). These results imply that
post-translational modification of PKC is important for its
activation. We have also found thqt PKC c is post-
translationally modified by ionising radiation. This post
translational modification was most clearly seen when cells
were treated with actinomycin D or cyclohexamide before
and after irradiation. Although we have not confirmed this
higher molecular weight protein as the phosphorylated form
of PKC 8, it has the same apparent molecular weight of the
phosphorylated form of PKC a as previously described by
Pfeffer et al. (Pfeffer et al., 1991). Since this post-translational
modification was seen when transcription and translation
were inhibited, we propose that a protease exists which nor-
mally degrades or inhibits the function of this post-
translational modification enzyme. Thus, the induction and
post-translational modification of PKC act in concert to
mediate cellular response to radiation damage. Further inves-
tigation is required to find the physiological significance of
these responses.
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